Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-14

FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for clozapine from Aurobindo Pharma Limited, enabling the marketed generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)